Jason Paul Steik
CIK: 0002078374
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PNTG
Pennant Group, Inc.
Officer
Discretionary Trading P&L
Holdings
About Steik Jason Paul
Steik Jason Paul (SEC CIK 0002078374) files insider reports with the SEC as Chief Clinical Officer of Pennant Group, Inc. (PNTG).
Signal8 holds 3 ownership filings by Steik Jason Paul (1 Form 3, 2 Form 4), filed between Jul 31, 2025 and Aug 10, 2026. Those filings report 2 transactions, from Mar 5, 2026 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Steik Jason Paul's filings is in EAGLE, ID.
Recent filings by Steik Jason Paul
Other insiders filing for Pennant Group, Inc. (PNTG)
- Gochnour John J, Chief Operating Officer
- COVEY STEPHEN M R, Director
- Morris Gregory K Sr., Director
- Snapper Suzanne D., Director
- SMITH BARRY M, Director
- Lamb Scott E, Director